HSG has completed the acquisition of an approximately 80% controlling stake in PeierTech, a manufacturer of medical-grade nitinol materials, precision components, and contract manufacturing services for medical device companies.
PeierTech’s existing management team will retain the remaining ownership and continue leading day-to-day operations following the transaction.
Founded in 2002 and headquartered in Jiangyin, Jiangsu Province, PeierTech supplies medical device manufacturers globally with nickel-titanium alloy materials, precision components, and assembly services.
Nitinol is widely used in minimally invasive medical devices because of properties including shape memory and superelasticity. PeierTech serves customers developing products where precision manufacturing, material quality, and regulatory consistency are particularly important.
HSG plans to support the company through additional capital, international operating experience, and industry relationships. The investor also intends to introduce a market-oriented incentive plan for PeierTech employees as part of the new ownership structure.
The partnership is expected to focus on international expansion, operating improvements, and opportunities for additional consolidation within specialized medical device manufacturing.
PeierTech’s management said the company intends to continue prioritizing customer relationships, technical support, manufacturing quality, and reliability as it grows under HSG ownership.
The transaction adds a specialized healthcare manufacturing business to HSG’s portfolio. The investment firm, formerly known as Sequoia China, invests globally across technology, healthcare, and consumer sectors and maintains offices in Hong Kong, Shanghai, Beijing, Shenzhen, London, Tokyo, and Singapore.
For PeierTech, the deal provides additional financial and strategic resources while preserving continuity through management’s retained equity ownership and ongoing leadership.
The company plans to use that support to strengthen its position with global medical device manufacturers and pursue additional growth in advanced nitinol materials and precision component manufacturing.
KEY QUOTES:
“HSG’s investment marks a new chapter for PeierTech, bringing financial support, international experience, and an extensive industry network that will help us pursue our next phase of growth.”
Amy Shen, CEO Of PeierTech
“We see significant opportunities to further strengthen its global position through international expansion, operational improvements, and market consolidation.”
Steve Jia, Partner At HSG
